Opinion: How Biotechs Can Prepare for the Next Decade by Rethinking Conventional Business Models
In today’s challenging environment, here are some creative ways biotechs have found to survive and thrive.
Uncategorized
Evofem Biosciences Announces Financial Results for the Third Quarter of 2023
Evofem Biosciences, Inc. (OTCQB: EVFM) today announced financial results for the third quarter and nine months ended September 30, 2023.
Evofem Biosciences Announces Financial Results for the Third Quarter of 2023 Read More »
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
Renalytix plc today reported financial results for the fiscal first quarter ended September 30, 2023.
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024 Read More »
Jazz Inks $770M Deal with GSK Spinout Autifony, Nabs Two Neuro Assets
Under the potential $770.5 million deal announced Tuesday, Autifony Therapeutics is licensing to Jazz Pharmaceuticals two ion channel targets associated with neurological disorders.
Jazz Inks $770M Deal with GSK Spinout Autifony, Nabs Two Neuro Assets Read More »
Crucial Data Solutions and nmible Join Forces to Provide a Solution for Seamless Participant Reimbursement in Clinical Trials
Crucial Data Solutions (CDS), the only SaaS platform to empower customer-driven global clinical trials for web and mobile environments, and nmible, a provider of cost effective clinical trial payment solutions, announced today they have formed a strategic
Xsphera Biosciences and NEX-I Collaborate to Advance Oncology Drug Research
Xsphera Biosciences, a leading biotechnology company specializing in ex vivo testing of oncology therapeutics on patient-excised tumor tissue, is pleased to announce the formalization of a Memorandum of Understanding (MOU) with NEX-I
Xsphera Biosciences and NEX-I Collaborate to Advance Oncology Drug Research Read More »
Biden initiative aims to accelerate women’s health research
AdvaMed endorsed the White House effort, stressing the need for equitable development and funding of new technologies.
Biden initiative aims to accelerate women’s health research Read More »
New AMA policies focus on GLP-1 coverage, resisting corporate medicine
The lobbying group advanced a range of policy resolutions it says will advance access to patient care at its annual interim meeting.
New AMA policies focus on GLP-1 coverage, resisting corporate medicine Read More »
Olympus receives Class I recall label for another bronchoscope safety issue
The company’s latest corrective action follows four reports of “endobronchial combustion” during procedures with its bronchoscopes.
Olympus receives Class I recall label for another bronchoscope safety issue Read More »
One Medical enters New Jersey through latest health system deal, with Hackensack Meridian Health
The partnership announced Tuesday adds another hospital operator to the company’s bench of health system affiliates. One Medical plans to open its first clinic in the Garden State by the end of next year.